Home/IsomAb/Julian Attfield

JA

Julian Attfield

Chief Financial Officer/Company Secretary

Therapeutic Areas

IsomAb Pipeline

Drug	Indication	Phase
ISM-001	Chronic Stable Angina (Coronary Artery Disease)	Pre-clinical

Leadership Team at IsomAb

Dr Philip Brainin

Chief Executive Officer

Professor David Bates

Chief Scientific Officer

Dr Gary Burgess

Chief Medical Officer

View full IsomAb profile